Summary

Overview
Global Healthcare Data Interoperability Market reached US$ XX billion in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Healthcare Interoperability refers to timely and secure access, integration, and use of electronic health data so that it can be used to optimize health outcomes for individuals and populations. Interoperability modernizes systems communications for better and quicker access to patient files across multiple healthcare facilities by using a common language.
Interoperability can help enhance patient data privacy and security by requiring organizations to fully assess how their private health information is being used and shared. The major role is to ensure that the data that is being transmitted and received are usable and immediately available to share.
Market Dynamics
The increasing adoption of digital healthcare solutions
The increasing adoption of digital healthcare solutions acts as a significant driver for market growth. Interoperability and data sharing will become increasingly important for delivering effective healthcare as populations worldwide age and people live longer lives. Interoperability enables organizations to examine data trends and past performance and make data-driven improvements in patient care and other areas.
For instance, in March 2023, EHR vendor NextGen Healthcare launched the Mirth Cloud Connect, a cloud-based solution that aims to streamline healthcare interoperability. The tool integrates patient data flow from multiple trusted sources for actionable insights at the point of care.
Additionally, in April 2023, Particle Health released a new feature called Particle for Platforms, which uses a single API to provide software-enabled healthcare organizations with interoperability. Along with access to other useful data sources, the service offers an interoperability gateway that connects to CommonWell Health Alliance, Carequality, and eHealth Exchange.
Furthermore, significant growth drivers such as increased investments to improve healthcare facilities, and favorable government initiatives to improve patient care are expected to drive the market in the forecast period.
Challenges associated with interoperability solutions
Despite the advancement and adoption of EHR technology, these systems continue to contribute to data silos, making interoperability a significant challenge. For instance, the lack of a national patient identifier is one of the most significant barriers to true EHR interoperability (NPID) where EHRs are the primary repositories and means of access to patient and health data, a major issue is the inability to identify patients and match patient records across and within healthcare provider settings.
Segment Analysis
The global healthcare data interoperability market is segmented based on level, type, end user, and region.
The EHR Interoperability segment accounted for approximately 48.5% of the market share
The EHR Interoperability segment is expected to hold the largest market share over the period forecast. Interoperable electronic health records (EHR) enable the electronic sharing of patient information between different EHR systems and healthcare providers, making it easier for doctors to provide care to their patients and move in and out of different care facilities. EHR is widely regarded as one of the simplest and most secure options that do not result in information blocking.
For instance, in May 2021, Automation Anywhere, Inc. launched its new cloud-based Epic Fast Healthcare Interoperability Resources (FHIR) API Bot to automate access to electronic health records (EHR) for Epic Systems which is one of the largest EHR vendors in the United States.
Additionally, in April 2023, Intermountain Health medical informaticists developed a clinical decision support platform that uses evidence-based medicine and artificial intelligence to accelerate patient treatment and integrate with electronic health records in real-time. Hence, due to the above factors, the segment is expected to hold the largest market share.
Geographical Analysis
North America is expected to hold a significant position in the global healthcare data interoperability market share
North America has maintained a significant market proportion due to factors such as the rising demand for digital healthcare services, product launches, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.
For instance, in February 2023, Redox, a leader in healthcare interoperability, and Google Cloud partnered to simplify the exchange of healthcare data so organizations can make better and faster decisions.
Additionally, in July 2023, GroundGame.Health (GGH) in partnership with USAing launched the new interoperability and data affinity group at the 2023 conference and tradeshow.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant positive impact on the global healthcare data interoperability market. From comprehending a single patient's entire medical journey to analyzing aggregated data at the community level, frontline providers and researchers require access to the most comprehensive data sets available to track the disease, determine which protocols are most effective, and stay ahead of the virus.
Interoperability has many benefits for measuring vaccine efficacy at the population level. Scientists can study the impact of vaccines on different populations and the implications of distribution inequities in traditionally underserved populations when data can be shared at the macro level.
Market Segmentation
By Level
• Foundational
• Structural
• Semantic
• Organizational
By Type
• Solutions
o EHR Interoperability
o HIE Interoperability
o Others
• Services
By End User
• Healthcare Providers
• Healthcare Payers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Koninklijke Philips N.V., Epic Systems Corporation, Veradigm LLC, Cerner Corporation, Orion Health, OSP Labs, CES Limited, NextGen Healthcare Inc., ViSolve Inc., and InterSystems Corporation among others.
Key Developments
• In October 2023, Philips introduced the interoperability of Philips Capsule Medical Device Information Platform (MDIP) with Philips Patient Information Center iX by providing hospitals with a first of its kind.
Why Purchase the Report?
• To visualize the global healthcare data interoperability market segmentation based on type, capsule size, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of healthcare data interoperability market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global healthcare data interoperability market report would provide approximately 61 tables, 63 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Level
3.2. Snippet by Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing adoption of digital healthcare solutions
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Challenges associated with interoperability solutions
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Level
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
7.1.2. Market Attractiveness Index, By Level
7.2. Foundational*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Structural
7.4. Semantic
7.5. Organizational
8. By Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.1.2. Market Attractiveness Index, By Type
8.2. Solutions*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. EHR Interoperability
8.2.4. HIE Interoperability
8.2.5. Others
8.3. Services
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Healthcare Providers*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Healthcare Payers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Koninklijke Philips N.V.
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Epic Systems Corporation
12.3. Veradigm LLC
12.4. Cerner Corporation
12.5. Orion Health
12.6. OSP Labs
12.7. CES Limited
12.8. NextGen Healthcare Inc.
12.9. ViSolve Inc.
12.10. InterSystems Corporation
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us